The Lynx Group

Howard Scher, MD

Authored Items

Liquid Biopsy Characterizing CTCs Can Aid in Treatment Selection

February 2016, Vol. 5, No. 1 - Genitourinary Cancers Symposium

A “liquid biopsy” using phlebotomy blood samples can identify phenotypes and genomic characteristics of circulating tumor cells (CTCs) that may help personalize treatment selection for men with advanced prostate cancer.“Hormonal agents prolong the lives of men with castrate-resistant prostate cancer. The optimal sequence of agents to maximize survival is unknown. [ Read More ]

Sign me up!